JNK dependent AMPA-R regulation GM Thomas et al Waetzig V, Herdegen T (2005) Context-speciﬁc inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol Sci 26: 455–461 Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda Y, Davis RJ (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671–1674 Wyszinski M, Kim E, Dunah AW, Passafaro M, Valtschanoff JG, Serra-Pages C, Streuli M, Weinberg RJ, Sheng M (2002) Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. Neuron 34: 39–52 Xia XG, Hardin T, Weller M, Bieneman A, Uney JB, Schulz JB (2001) Gene transfer of the JNK interacting protein-1 protects dopami- nergic neurons in the MPTP model of Parkinson’s disease. Proc Natl Acad Sci USA 98: 10433–10438 Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865–870 Zhu JJ, Esteban JA, Hayashi Y, Malinow R (2000) Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci 3: 1098–1106 Zhu JJ, Qin Y, Zhao M, Van Aelst L, Malinow R (2002) Ras and Rap control AMPA receptor trafﬁcking during synaptic plasticity. Cell 110: 443–455 Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP, Velamoor V, Auberson YP, Osten P, Van Aelst L, Sheng M, Zhu JJ (2005) Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron 46: 905–916 The EMBO Journal is published by Nature Publishing Group on behalf of European Molecular Biology Organization. This article is licensed under a Creative Commons Attribution License <http:// creativecommons.org/licenses/by/2.5/> 372 The EMBO Journal VOL 27 | NO 2 | 2008 & 2008 European Molecular Biology Organization